AJP - Lung Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 287: L201-L209, 2004. First published March 12, 2004; doi:10.1152/ajplung.00293.2003
1040-0605/04 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
287/1/L201    most recent
00293.2003v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ono, K.
Right arrow Articles by Hasegawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ono, K.
Right arrow Articles by Hasegawa, K.

Contribution of caveolin-1{alpha} and Akt to TNF-{alpha}-induced cell death

Koh Ono,1 Yoshitaka Iwanaga,2 Madoka Hirayama,3 Teruhisa Kawamura,4 Naoya Sowa,4 and Koji Hasegawa1

1Division of Translational Research, Kyoto Medical Center, National Hospital Organization, Kyoto 612-8555; Departments of 2Cardiology and 3Pharmacology, Research Institute, National Cardiovascular Center, Osaka 565-8565; and 4Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto 606-8507, Japan

Submitted 27 August 2003 ; accepted in final form 5 March 2004

We used retrovirus insertion-mediated random mutagenesis to generate tumor necrosis factor-{alpha} (TNF-{alpha})-resistant lines from L929 cells. Using this approach, we discovered that caveolin-1{alpha} is required for TNF-{alpha}-induced cell death in L929 cells. The need for caveolin-1{alpha} in TNF-{alpha}-induced cell death was confirmed by the restoration of sensitivity to TNF-{alpha} after ectopic reconstitution of caveolin-1{alpha}/{beta} expression. This caveolin-1{alpha}-mutated line was also resistant to H2O2 and staurosporine, but not to lonidamine. HepG2 cells are known to lack endogenous caveolins. HepG2 cells stably transfected with caveolin-1{alpha}/{beta} were found to be much more sensitive to TNF-{alpha} than either parental cells transfected with caveolin-1{beta} or parental cells transfected with an empty vector. In contrast to its extensively documented antiapoptotic effect, the elevated activity of Akt appears to be important in sensitizing caveolin-1-expressing cells to TNF-{alpha}, since pretreatment of cells with the phosphatidylinositide 3-kinase (PI3K) inhibitor LY-294002 or wortmannin completely blocked PI3K activation and markedly improved the survival of TNF-{alpha}-treated L929 cells. The survival rates of caveolin-1{alpha}-normal and caveolin-1{alpha}-deficient L929 cells were comparable after treatment with PI3K inhibitor and TNF-{alpha}. Similar results were obtained with HepG2 cells that stably expressed caveolin-1{alpha}/{beta} or -{beta} and parental cells transfected with an empty vector. In summary, our results indicate that caveolin-1{alpha} preferentially sensitizes L929 cells to TNF-{alpha} through the activation of a PI3K/Akt signaling pathway.

caveolin; tumor necrosis factor; phosphatidylinositol 3-kinase



Address for reprint requests and other correspondence: K. Ono, Division of Translational Research, Kyoto Medical Center, National Hospital Organization, 1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto 612-8555, Japan (E-mail: kohono{at}kuhp.kyoto-u.ac.jp).




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
S. Chintharlapalli, S. Papineni, and S. Safe
1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes inhibit colon cancer cell and tumor growth through PPAR{gamma}-dependent and PPAR{gamma}-independent pathways
Mol. Cancer Ther., May 1, 2006; 5(5): 1362 - 1370.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
V. A. Torres, J. C. Tapia, D. A. Rodriguez, M. Parraga, P. Lisboa, M. Montoya, L. Leyton, and A. F. G. Quest
Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin
J. Cell Sci., May 1, 2006; 119(9): 1812 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. Kassouf, S. Chintharlapalli, M. Abdelrahim, G. Nelkin, S. Safe, and A. M. Kamat
Inhibition of Bladder Tumor Growth by 1,1-Bis(3'-Indolyl)-1-(p-Substitutedphenyl)Methanes: A New Class of Peroxisome Proliferator-Activated Receptor {gamma} Agonists
Cancer Res., January 1, 2006; 66(1): 412 - 418.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2004 by the American Physiological Society.